pneumocystoses

pneumocystoses commonly affects immunocompromised patients.

early diagnosis of pneumocystoses improves survival rates.

prophylaxis can prevent pneumocystoses in at-risk individuals.

the symptoms of pneumocystoses include fever and dry cough.

treatment for pneumocystoses involves antimicrobial therapy.

hiv/aids patients are particularly vulnerable to pneumocystoses.

chest x-rays often reveal patterns characteristic of pneumocystoses.

corticosteroids are sometimes used alongside pneumocystoses treatment.

transmission of pneumocystoses occurs through airborne droplets.

laboratory tests confirm the presence of pneumocystoses.

mortality from pneumocystoses remains high without treatment.

trimethoprim-sulfamethoxazole is first-line therapy for pneumocystoses.